Candriam S.C.A. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 153 filers reported holding IMMUNOGEN INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2023$33,286,538
+86.8%
1,122,598
+0.0%
0.23%
+82.5%
Q3 2023$17,815,472
-4.9%
1,122,588
+13.1%
0.13%
-6.7%
Q2 2023$18,730,023
+121.8%
992,582
-58.5%
0.14%
+128.8%
Q1 2023$8,444,872
-36.7%
2,389,296
-11.2%
0.06%
-34.4%
Q4 2022$13,338,283
-2.3%
2,689,296
-5.8%
0.09%
-6.2%
Q3 2022$13,646,000
+187.0%
2,854,635
+170.2%
0.10%
+146.2%
Q2 2022$4,754,000
-67.3%
1,056,439
-58.8%
0.04%
-60.6%
Q3 2021$14,532,000
-10.4%
2,562,935
+4.1%
0.10%
-10.8%
Q2 2021$16,221,000
+1196.6%
2,461,459
+325.0%
0.11%
+593.8%
Q2 2019$1,251,000
-60.0%
579,210
-49.8%
0.02%
-60.0%
Q1 2019$3,129,000
-36.2%
1,154,721
+13.1%
0.04%
-46.7%
Q4 2018$4,901,000
-45.7%
1,021,139
+7.2%
0.08%
-37.5%
Q3 2018$9,020,000
+33.6%
952,500
+37.2%
0.12%
+12.1%
Q2 2018$6,753,000
+8.1%
694,000
+16.8%
0.11%0.0%
Q1 2018$6,249,000
+71.0%
594,000
+4.2%
0.11%
+69.8%
Q4 2017$3,654,000
-16.2%
570,0000.0%0.06%
-17.1%
Q3 2017$4,361,000
+7.6%
570,0000.0%0.08%0.0%
Q2 2017$4,053,000
+129.9%
570,000
+174.0%
0.08%
+72.7%
Q1 2016$1,763,000
-45.4%
208,000
-12.6%
0.04%
-48.8%
Q4 2015$3,231,000
+41.3%
238,1000.0%0.09%
+53.6%
Q3 2015$2,286,000
-47.0%
238,100
-20.6%
0.06%
-37.8%
Q2 2015$4,314,000
+33.9%
300,000
-16.7%
0.09%
+38.5%
Q1 2015$3,223,000
+8.9%
360,000
-25.8%
0.06%
+4.8%
Q4 2014$2,959,000485,0000.06%
Other shareholders
IMMUNOGEN INC shareholders Q3 2015
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders